| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemangioma | 30 | 2023 | 727 | 3.110 |
Why?
|
| Vascular Malformations | 12 | 2024 | 468 | 1.510 |
Why?
|
| Hemangioendothelioma | 9 | 2016 | 111 | 1.000 |
Why?
|
| Neoplasms, Connective Tissue | 2 | 2021 | 36 | 0.890 |
Why?
|
| Subcutaneous Tissue | 1 | 2021 | 132 | 0.750 |
Why?
|
| Granuloma, Pyogenic | 4 | 2020 | 47 | 0.690 |
Why?
|
| Neoplasms, Vascular Tissue | 3 | 2012 | 25 | 0.680 |
Why?
|
| Soft Tissue Neoplasms | 14 | 2017 | 1159 | 0.660 |
Why?
|
| Arteriovenous Malformations | 9 | 2022 | 396 | 0.580 |
Why?
|
| Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 1 | 2017 | 6 | 0.570 |
Why?
|
| Vascular Neoplasms | 4 | 2014 | 166 | 0.560 |
Why?
|
| Infant | 90 | 2024 | 36192 | 0.520 |
Why?
|
| Hemangioma, Capillary | 3 | 2015 | 64 | 0.520 |
Why?
|
| Hamartoma Syndrome, Multiple | 3 | 2012 | 114 | 0.510 |
Why?
|
| Child, Preschool | 84 | 2024 | 42230 | 0.500 |
Why?
|
| Lipoma | 5 | 2012 | 293 | 0.490 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2017 | 233 | 0.490 |
Why?
|
| Lymphatic Abnormalities | 4 | 2023 | 134 | 0.490 |
Why?
|
| Acidosis | 1 | 2017 | 268 | 0.480 |
Why?
|
| Microvilli | 1 | 2015 | 234 | 0.470 |
Why?
|
| Skin Neoplasms | 13 | 2024 | 5821 | 0.470 |
Why?
|
| Immunohistochemistry | 21 | 2024 | 11076 | 0.470 |
Why?
|
| Mucolipidoses | 1 | 2015 | 82 | 0.460 |
Why?
|
| Malabsorption Syndromes | 1 | 2015 | 135 | 0.460 |
Why?
|
| Angiomatosis | 3 | 2014 | 46 | 0.450 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 3 | 2011 | 41 | 0.430 |
Why?
|
| Bone Neoplasms | 11 | 2015 | 2529 | 0.420 |
Why?
|
| Child | 94 | 2024 | 80153 | 0.410 |
Why?
|
| Endothelial Cells | 6 | 2024 | 3548 | 0.400 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2012 | 119 | 0.400 |
Why?
|
| Infant, Newborn | 54 | 2023 | 26198 | 0.390 |
Why?
|
| Abnormalities, Multiple | 7 | 2015 | 1423 | 0.390 |
Why?
|
| Lung | 9 | 2022 | 10000 | 0.380 |
Why?
|
| Lymphatic Diseases | 3 | 2018 | 320 | 0.370 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2014 | 488 | 0.370 |
Why?
|
| Bronchopulmonary Sequestration | 2 | 2011 | 43 | 0.360 |
Why?
|
| Vascular Diseases | 2 | 2012 | 1161 | 0.360 |
Why?
|
| Thrombocytopenia | 6 | 2014 | 1181 | 0.350 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2024 | 147 | 0.340 |
Why?
|
| GTP-Binding Protein alpha Subunits | 2 | 2023 | 102 | 0.340 |
Why?
|
| Hypoglycemia | 1 | 2017 | 883 | 0.330 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 1134 | 0.330 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2010 | 117 | 0.320 |
Why?
|
| Muscle, Skeletal | 6 | 2020 | 4948 | 0.310 |
Why?
|
| Pulmonary Atresia | 2 | 2006 | 159 | 0.310 |
Why?
|
| Skin Diseases | 3 | 2020 | 1094 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 368 | 0.290 |
Why?
|
| Liposarcoma | 1 | 2010 | 289 | 0.290 |
Why?
|
| Adolescent | 72 | 2024 | 88319 | 0.280 |
Why?
|
| Myxoma | 2 | 2018 | 114 | 0.280 |
Why?
|
| Sarcoma, Kaposi | 3 | 2016 | 374 | 0.270 |
Why?
|
| Capillaries | 2 | 2024 | 755 | 0.270 |
Why?
|
| Liver Neoplasms | 11 | 2015 | 4320 | 0.260 |
Why?
|
| Fatty Acid-Binding Proteins | 3 | 2015 | 296 | 0.260 |
Why?
|
| Male | 127 | 2024 | 360804 | 0.260 |
Why?
|
| Skin Ulcer | 1 | 2007 | 130 | 0.260 |
Why?
|
| Diagnosis, Differential | 27 | 2020 | 12974 | 0.260 |
Why?
|
| Sudden Infant Death | 4 | 2017 | 292 | 0.260 |
Why?
|
| Female | 129 | 2024 | 392644 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2004 | 367 | 0.250 |
Why?
|
| Bone and Bones | 4 | 2013 | 2568 | 0.240 |
Why?
|
| Neovascularization, Pathologic | 2 | 2012 | 2645 | 0.240 |
Why?
|
| Humans | 183 | 2024 | 761504 | 0.240 |
Why?
|
| Carcinoma, Small Cell | 1 | 2007 | 420 | 0.240 |
Why?
|
| Scalp Dermatoses | 1 | 2005 | 44 | 0.240 |
Why?
|
| Lymphatic Vessels | 1 | 2008 | 358 | 0.230 |
Why?
|
| Osteochondroma | 1 | 2004 | 44 | 0.230 |
Why?
|
| Lung Diseases | 3 | 2010 | 1909 | 0.230 |
Why?
|
| Rhabdomyosarcoma | 5 | 2015 | 358 | 0.230 |
Why?
|
| Nevus, Blue | 1 | 2024 | 43 | 0.230 |
Why?
|
| Oncogene Proteins, Fusion | 4 | 2017 | 1606 | 0.230 |
Why?
|
| Mutation | 13 | 2023 | 30052 | 0.220 |
Why?
|
| Neuroblastoma | 8 | 2008 | 1250 | 0.220 |
Why?
|
| Hemangiosarcoma | 2 | 2008 | 215 | 0.220 |
Why?
|
| Nitric Oxide | 1 | 2012 | 2135 | 0.220 |
Why?
|
| Choristoma | 1 | 2005 | 206 | 0.210 |
Why?
|
| Meninges | 1 | 2005 | 198 | 0.210 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2014 | 1432 | 0.210 |
Why?
|
| Sclerotherapy | 4 | 2019 | 182 | 0.210 |
Why?
|
| Lymphatic System | 2 | 2008 | 254 | 0.210 |
Why?
|
| Fibrosarcoma | 3 | 2017 | 309 | 0.210 |
Why?
|
| Chromosomes, Human, X | 1 | 2004 | 321 | 0.200 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2010 | 2917 | 0.200 |
Why?
|
| Upper Extremity | 2 | 2019 | 657 | 0.190 |
Why?
|
| Translocation, Genetic | 3 | 2004 | 1393 | 0.190 |
Why?
|
| Adrenal Gland Neoplasms | 4 | 2008 | 732 | 0.190 |
Why?
|
| Nephroma, Mesoblastic | 2 | 2017 | 24 | 0.190 |
Why?
|
| Osteosarcoma | 3 | 1994 | 897 | 0.190 |
Why?
|
| Respiratory Insufficiency | 1 | 2010 | 1230 | 0.190 |
Why?
|
| Chromosome Aberrations | 8 | 2007 | 1768 | 0.190 |
Why?
|
| Osteolysis, Essential | 2 | 2013 | 30 | 0.180 |
Why?
|
| Pulmonary Emphysema | 1 | 2006 | 684 | 0.180 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2002 | 335 | 0.180 |
Why?
|
| Giant Cells | 1 | 2001 | 188 | 0.180 |
Why?
|
| Blood Vessels | 3 | 2010 | 1113 | 0.180 |
Why?
|
| Kidney Neoplasms | 6 | 2017 | 4249 | 0.170 |
Why?
|
| Adrenal Cortex Neoplasms | 2 | 2011 | 161 | 0.170 |
Why?
|
| Fatal Outcome | 7 | 2010 | 1834 | 0.170 |
Why?
|
| Immunoenzyme Techniques | 5 | 2009 | 1705 | 0.170 |
Why?
|
| Signal Transduction | 5 | 2023 | 23445 | 0.170 |
Why?
|
| Femoral Neoplasms | 2 | 1991 | 84 | 0.160 |
Why?
|
| Intestinal Obstruction | 2 | 2009 | 432 | 0.160 |
Why?
|
| Lower Extremity | 2 | 2020 | 1202 | 0.160 |
Why?
|
| Neuroglia | 1 | 2005 | 956 | 0.160 |
Why?
|
| Hepatoblastoma | 2 | 2010 | 90 | 0.160 |
Why?
|
| Myofibroma | 2 | 2011 | 45 | 0.150 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2019 | 332 | 0.150 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 3 | 2017 | 899 | 0.150 |
Why?
|
| Hamartoma | 2 | 2017 | 235 | 0.150 |
Why?
|
| Thyroid Nodule | 3 | 2013 | 764 | 0.140 |
Why?
|
| Asphyxia | 1 | 2017 | 60 | 0.140 |
Why?
|
| Radiography | 10 | 2014 | 6965 | 0.140 |
Why?
|
| Glucose Transporter Type 1 | 2 | 2008 | 186 | 0.140 |
Why?
|
| Gastrointestinal Diseases | 1 | 2005 | 1200 | 0.140 |
Why?
|
| Lipomatosis | 1 | 2017 | 112 | 0.130 |
Why?
|
| Placenta | 3 | 2012 | 1709 | 0.130 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2024 | 954 | 0.130 |
Why?
|
| In Situ Hybridization, Fluorescence | 10 | 2017 | 2510 | 0.130 |
Why?
|
| Retrospective Studies | 32 | 2021 | 80636 | 0.130 |
Why?
|
| Testicular Neoplasms | 3 | 2015 | 799 | 0.130 |
Why?
|
| Skin Abnormalities | 1 | 2016 | 59 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 4 | 2024 | 694 | 0.130 |
Why?
|
| Heart Neoplasms | 2 | 2012 | 362 | 0.130 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2017 | 210 | 0.130 |
Why?
|
| Muscular Diseases | 1 | 2020 | 553 | 0.130 |
Why?
|
| Nuclear Proteins | 2 | 2010 | 5796 | 0.130 |
Why?
|
| Cell Proliferation | 3 | 2015 | 10445 | 0.120 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2015 | 17 | 0.120 |
Why?
|
| GTP Phosphohydrolases | 1 | 2018 | 517 | 0.120 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2000 | 589 | 0.120 |
Why?
|
| Cysts | 2 | 1998 | 681 | 0.120 |
Why?
|
| Endodermal Sinus Tumor | 1 | 2015 | 53 | 0.120 |
Why?
|
| Endothelium, Lymphatic | 2 | 2024 | 63 | 0.120 |
Why?
|
| Epidermal Cyst | 2 | 2011 | 64 | 0.120 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 2015 | 38 | 0.120 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 1 | 2015 | 69 | 0.120 |
Why?
|
| Genes, Wilms Tumor | 3 | 2005 | 92 | 0.120 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 502 | 0.120 |
Why?
|
| Receptors, FSH | 1 | 2014 | 29 | 0.120 |
Why?
|
| Intestinal Perforation | 1 | 1996 | 249 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 4 | 2008 | 9177 | 0.110 |
Why?
|
| Gene Fusion | 1 | 2017 | 356 | 0.110 |
Why?
|
| Pulmonary Blastoma | 2 | 2006 | 41 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2015 | 2865 | 0.110 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2014 | 45 | 0.110 |
Why?
|
| Boston | 6 | 2022 | 9326 | 0.110 |
Why?
|
| Subcutaneous Fat | 1 | 2017 | 393 | 0.110 |
Why?
|
| Pregnancy in Diabetics | 1 | 1995 | 197 | 0.110 |
Why?
|
| Keratins | 4 | 2010 | 498 | 0.110 |
Why?
|
| Jaw Neoplasms | 2 | 2011 | 70 | 0.110 |
Why?
|
| Ileum | 1 | 1996 | 557 | 0.110 |
Why?
|
| Glomus Tumor | 1 | 2014 | 62 | 0.110 |
Why?
|
| Ultrasonography | 7 | 2014 | 5972 | 0.110 |
Why?
|
| Fascia | 1 | 2014 | 140 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 4575 | 0.110 |
Why?
|
| Karyotyping | 8 | 2006 | 1171 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 9420 | 0.110 |
Why?
|
| Dermatoglyphics | 1 | 1992 | 20 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 8547 | 0.110 |
Why?
|
| Uveal Neoplasms | 1 | 2016 | 341 | 0.110 |
Why?
|
| Infant, Premature, Diseases | 2 | 1996 | 710 | 0.100 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2013 | 80 | 0.100 |
Why?
|
| Muscle Neoplasms | 1 | 2014 | 130 | 0.100 |
Why?
|
| Prenatal Diagnosis | 3 | 2011 | 1265 | 0.100 |
Why?
|
| Tibia | 4 | 2013 | 1070 | 0.100 |
Why?
|
| Serotonin | 1 | 2017 | 1041 | 0.100 |
Why?
|
| Serine Endopeptidases | 1 | 2017 | 1022 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 1076 | 0.100 |
Why?
|
| Transcription Factors | 3 | 2010 | 12128 | 0.100 |
Why?
|
| Skin | 2 | 2024 | 4484 | 0.100 |
Why?
|
| Gingival Neoplasms | 1 | 2011 | 20 | 0.100 |
Why?
|
| Lymph Nodes | 3 | 2013 | 3466 | 0.100 |
Why?
|
| Muscle, Smooth | 1 | 1996 | 926 | 0.100 |
Why?
|
| Neoplasm Proteins | 3 | 2015 | 3617 | 0.100 |
Why?
|
| Neoplasm Staging | 11 | 2015 | 11121 | 0.100 |
Why?
|
| Lip | 1 | 1993 | 197 | 0.100 |
Why?
|
| Follow-Up Studies | 15 | 2018 | 39106 | 0.100 |
Why?
|
| Keratosis | 2 | 2015 | 79 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 19 | 2020 | 36426 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2017 | 9280 | 0.100 |
Why?
|
| Brain Neoplasms | 3 | 2017 | 9031 | 0.100 |
Why?
|
| Enchondromatosis | 1 | 2011 | 14 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1745 | 0.100 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2011 | 29 | 0.090 |
Why?
|
| Adenoma | 4 | 2010 | 2160 | 0.090 |
Why?
|
| Testicular Diseases | 1 | 2011 | 73 | 0.090 |
Why?
|
| alpha-Fetoproteins | 1 | 2011 | 223 | 0.090 |
Why?
|
| Neonatal Screening | 1 | 2015 | 597 | 0.090 |
Why?
|
| Mesenchymoma | 1 | 1991 | 49 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2012 | 1115 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 452 | 0.090 |
Why?
|
| Fibroma | 2 | 2005 | 190 | 0.090 |
Why?
|
| Adult | 38 | 2018 | 221177 | 0.090 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2010 | 31 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 1995 | 1493 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 3 | 2007 | 695 | 0.090 |
Why?
|
| Diaphragm | 1 | 2012 | 351 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2011 | 223 | 0.090 |
Why?
|
| Genital Neoplasms, Female | 2 | 2005 | 532 | 0.090 |
Why?
|
| Pulmonary Artery | 2 | 1995 | 1927 | 0.090 |
Why?
|
| Young Adult | 13 | 2015 | 59243 | 0.080 |
Why?
|
| Iodide Peroxidase | 2 | 2002 | 294 | 0.080 |
Why?
|
| Registries | 3 | 2015 | 8224 | 0.080 |
Why?
|
| Thyroid Neoplasms | 4 | 2013 | 2332 | 0.080 |
Why?
|
| Gynecomastia | 1 | 2010 | 87 | 0.080 |
Why?
|
| Glomus Jugulare Tumor | 1 | 2009 | 35 | 0.080 |
Why?
|
| Thyroid Gland | 3 | 2013 | 1168 | 0.080 |
Why?
|
| Biopsy | 8 | 2017 | 6766 | 0.080 |
Why?
|
| Carotid Body Tumor | 1 | 2009 | 34 | 0.080 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2012 | 307 | 0.080 |
Why?
|
| Embolization, Therapeutic | 2 | 2018 | 1418 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2009 | 748 | 0.080 |
Why?
|
| Humerus | 1 | 1991 | 272 | 0.080 |
Why?
|
| Microdissection | 1 | 2009 | 151 | 0.080 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2008 | 29 | 0.080 |
Why?
|
| Hypertension, Pulmonary | 2 | 2000 | 1578 | 0.080 |
Why?
|
| Diagnostic Imaging | 2 | 2016 | 3530 | 0.080 |
Why?
|
| Spinal Neoplasms | 3 | 2009 | 716 | 0.080 |
Why?
|
| Adamantinoma | 1 | 2008 | 9 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1349 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 1738 | 0.080 |
Why?
|
| Mesentery | 1 | 2009 | 202 | 0.080 |
Why?
|
| Genetic Markers | 3 | 2012 | 2601 | 0.080 |
Why?
|
| Carcinoma | 4 | 2017 | 2330 | 0.080 |
Why?
|
| Treatment Outcome | 13 | 2020 | 64680 | 0.080 |
Why?
|
| Cleft Lip | 1 | 1993 | 506 | 0.070 |
Why?
|
| Intracranial Aneurysm | 1 | 2018 | 1285 | 0.070 |
Why?
|
| Intestinal Volvulus | 1 | 2009 | 82 | 0.070 |
Why?
|
| Nipples | 1 | 2009 | 229 | 0.070 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 2008 | 53 | 0.070 |
Why?
|
| Testis | 1 | 2011 | 794 | 0.070 |
Why?
|
| Syndrome | 4 | 2010 | 3267 | 0.070 |
Why?
|
| Macrophages, Alveolar | 1 | 2010 | 412 | 0.070 |
Why?
|
| Adiposity | 1 | 2017 | 1878 | 0.070 |
Why?
|
| Recurrence | 7 | 2020 | 8465 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 1902 | 0.070 |
Why?
|
| Fibroblasts | 4 | 2006 | 4141 | 0.070 |
Why?
|
| Tissue Engineering | 3 | 2006 | 1868 | 0.070 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2009 | 592 | 0.070 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2010 | 326 | 0.070 |
Why?
|
| Angiokeratoma | 1 | 2006 | 5 | 0.070 |
Why?
|
| Sarcoma | 2 | 2017 | 1801 | 0.070 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2013 | 938 | 0.070 |
Why?
|
| Cell Lineage | 1 | 2015 | 2555 | 0.070 |
Why?
|
| Gene Expression | 2 | 2012 | 7581 | 0.070 |
Why?
|
| Prognosis | 11 | 2015 | 29625 | 0.070 |
Why?
|
| Thyroid Diseases | 1 | 2010 | 386 | 0.070 |
Why?
|
| Umbilical Cord | 1 | 2007 | 177 | 0.070 |
Why?
|
| Hypothyroidism | 2 | 2002 | 668 | 0.070 |
Why?
|
| Membrane Proteins | 3 | 2018 | 7856 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2015 | 20570 | 0.070 |
Why?
|
| Hypertrophy | 3 | 2017 | 561 | 0.070 |
Why?
|
| Port-Wine Stain | 1 | 2006 | 33 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2017 | 1642 | 0.070 |
Why?
|
| RNA, Neoplasm | 1 | 2009 | 750 | 0.070 |
Why?
|
| Balanitis | 1 | 2005 | 3 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 3448 | 0.070 |
Why?
|
| Pedigree | 2 | 2011 | 4542 | 0.060 |
Why?
|
| Vesicular Transport Proteins | 1 | 2008 | 376 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 1616 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2015 | 23995 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2007 | 368 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 2822 | 0.060 |
Why?
|
| Fibromatosis, Gingival | 1 | 2005 | 7 | 0.060 |
Why?
|
| Fetal Diseases | 2 | 2006 | 913 | 0.060 |
Why?
|
| Hyperplasia | 2 | 2010 | 1152 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 6 | 2015 | 3514 | 0.060 |
Why?
|
| Hyalin | 1 | 2005 | 34 | 0.060 |
Why?
|
| Vulva | 1 | 2005 | 84 | 0.060 |
Why?
|
| Family Health | 1 | 2010 | 1257 | 0.060 |
Why?
|
| Sclerosing Solutions | 1 | 2005 | 79 | 0.060 |
Why?
|
| Telangiectasis | 1 | 2005 | 78 | 0.060 |
Why?
|
| Adenocarcinoma, Follicular | 2 | 2010 | 323 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2008 | 2825 | 0.060 |
Why?
|
| Spectral Karyotyping | 1 | 2004 | 12 | 0.060 |
Why?
|
| Collagen | 3 | 2006 | 2638 | 0.060 |
Why?
|
| beta Catenin | 1 | 2010 | 1040 | 0.060 |
Why?
|
| Pain | 1 | 2020 | 5073 | 0.060 |
Why?
|
| Lasers | 1 | 2009 | 952 | 0.060 |
Why?
|
| Urachus | 1 | 2004 | 18 | 0.060 |
Why?
|
| Osteomyelitis | 1 | 1989 | 407 | 0.060 |
Why?
|
| Liver | 5 | 2011 | 7529 | 0.060 |
Why?
|
| Microscopy, Electron | 6 | 2005 | 2561 | 0.060 |
Why?
|
| Paramyxoviridae Infections | 1 | 2004 | 57 | 0.060 |
Why?
|
| Autopsy | 3 | 2017 | 1008 | 0.060 |
Why?
|
| Laryngeal Neoplasms | 1 | 2008 | 514 | 0.060 |
Why?
|
| Adipose Tissue | 3 | 2014 | 3312 | 0.060 |
Why?
|
| Arm | 1 | 2007 | 589 | 0.060 |
Why?
|
| Dermoid Cyst | 1 | 2005 | 92 | 0.060 |
Why?
|
| Mouth Abnormalities | 1 | 2003 | 19 | 0.060 |
Why?
|
| Hallux | 1 | 2004 | 43 | 0.060 |
Why?
|
| Jugular Veins | 1 | 2005 | 210 | 0.060 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2005 | 170 | 0.060 |
Why?
|
| Iliac Artery | 1 | 2005 | 343 | 0.060 |
Why?
|
| Metaplasia | 2 | 2021 | 322 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2007 | 727 | 0.060 |
Why?
|
| Wilms Tumor | 3 | 2001 | 379 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 1 | 2006 | 393 | 0.050 |
Why?
|
| Sturge-Weber Syndrome | 1 | 2024 | 89 | 0.050 |
Why?
|
| Hydrogels | 2 | 2006 | 720 | 0.050 |
Why?
|
| Veins | 2 | 2005 | 768 | 0.050 |
Why?
|
| Sex Distribution | 3 | 2014 | 2281 | 0.050 |
Why?
|
| Antigens, CD34 | 1 | 2005 | 658 | 0.050 |
Why?
|
| Combined Modality Therapy | 8 | 2013 | 8529 | 0.050 |
Why?
|
| Sertoli Cell Tumor | 1 | 1983 | 36 | 0.050 |
Why?
|
| Occipital Lobe | 1 | 2005 | 374 | 0.050 |
Why?
|
| Heart Failure | 1 | 2007 | 11669 | 0.050 |
Why?
|
| Cardiac Output, High | 1 | 2002 | 6 | 0.050 |
Why?
|
| Actins | 2 | 2011 | 2050 | 0.050 |
Why?
|
| Vulvar Neoplasms | 1 | 2005 | 263 | 0.050 |
Why?
|
| Survival Rate | 6 | 2015 | 12725 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2009 | 1206 | 0.050 |
Why?
|
| Time Factors | 8 | 2015 | 39967 | 0.050 |
Why?
|
| Tongue Diseases | 1 | 2002 | 68 | 0.050 |
Why?
|
| Peritoneal Neoplasms | 1 | 2009 | 711 | 0.050 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2004 | 201 | 0.050 |
Why?
|
| Infant Welfare | 1 | 2002 | 80 | 0.050 |
Why?
|
| Leg | 1 | 2007 | 1088 | 0.050 |
Why?
|
| Sinoatrial Node | 1 | 1982 | 99 | 0.050 |
Why?
|
| Necrosis | 4 | 2015 | 1611 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2010 | 1858 | 0.050 |
Why?
|
| Lung Neoplasms | 5 | 2010 | 13380 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2010 | 2909 | 0.050 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2007 | 617 | 0.050 |
Why?
|
| Chromosome Deletion | 2 | 1998 | 1386 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 7 | 2010 | 11742 | 0.050 |
Why?
|
| Wound Healing | 1 | 2012 | 2805 | 0.050 |
Why?
|
| Breast Neoplasms | 3 | 2021 | 21012 | 0.050 |
Why?
|
| DNA | 1 | 2015 | 7212 | 0.050 |
Why?
|
| Stromal Cells | 3 | 2017 | 1330 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2010 | 1545 | 0.050 |
Why?
|
| Neoplasms, Second Primary | 1 | 2008 | 1052 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3778 | 0.040 |
Why?
|
| Cause of Death | 1 | 2011 | 3683 | 0.040 |
Why?
|
| Alopecia | 1 | 2005 | 412 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 8 | 3 | 2001 | 452 | 0.040 |
Why?
|
| Cohort Studies | 5 | 2017 | 41487 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 3 | 2015 | 3595 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2017 | 314 | 0.040 |
Why?
|
| DNA-Binding Proteins | 4 | 2001 | 9606 | 0.040 |
Why?
|
| Papillomaviridae | 2 | 1997 | 1119 | 0.040 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2000 | 70 | 0.040 |
Why?
|
| Parietal Lobe | 1 | 2005 | 852 | 0.040 |
Why?
|
| Tongue | 1 | 2002 | 403 | 0.040 |
Why?
|
| Bronchiolitis, Viral | 1 | 2000 | 82 | 0.040 |
Why?
|
| Brain | 2 | 2024 | 27112 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 15842 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2024 | 2803 | 0.040 |
Why?
|
| Artificial Gene Fusion | 1 | 1998 | 56 | 0.040 |
Why?
|
| Gene Rearrangement | 3 | 2017 | 1125 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2022 | 1991 | 0.040 |
Why?
|
| Genetic Variation | 3 | 2018 | 6567 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 2 | 2017 | 2020 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2000 | 231 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2016 | 12795 | 0.040 |
Why?
|
| Urinary Bladder | 2 | 1997 | 1152 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2000 | 418 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2000 | 343 | 0.040 |
Why?
|
| Chondroblastoma | 1 | 1998 | 47 | 0.040 |
Why?
|
| Pregnancy | 5 | 2012 | 29874 | 0.040 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2000 | 213 | 0.040 |
Why?
|
| Phenotype | 3 | 2017 | 16591 | 0.040 |
Why?
|
| Biopsy, Needle | 2 | 1996 | 1626 | 0.040 |
Why?
|
| Dissection | 1 | 2020 | 298 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2006 | 1726 | 0.040 |
Why?
|
| Pneumonia | 1 | 2010 | 2143 | 0.040 |
Why?
|
| Chromosome Inversion | 1 | 1998 | 120 | 0.040 |
Why?
|
| Pericytes | 1 | 2001 | 293 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2007 | 6343 | 0.040 |
Why?
|
| Endometrium | 1 | 2001 | 403 | 0.040 |
Why?
|
| Diploidy | 1 | 1998 | 132 | 0.040 |
Why?
|
| Mitotic Index | 1 | 1998 | 162 | 0.040 |
Why?
|
| Urethral Neoplasms | 1 | 1997 | 37 | 0.040 |
Why?
|
| Histocytochemistry | 5 | 1998 | 698 | 0.040 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 2017 | 93 | 0.040 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 1998 | 198 | 0.040 |
Why?
|
| Gadolinium DTPA | 2 | 1998 | 823 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2018 | 6075 | 0.040 |
Why?
|
| Pleural Effusion, Malignant | 1 | 1998 | 106 | 0.040 |
Why?
|
| Melanoma | 1 | 2016 | 5709 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2014 | 6484 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1998 | 361 | 0.040 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 1995 | 82 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1998 | 430 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2017 | 2986 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2015 | 1784 | 0.040 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2000 | 283 | 0.030 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2017 | 55 | 0.030 |
Why?
|
| Hypospadias | 1 | 1997 | 97 | 0.030 |
Why?
|
| Glycine | 1 | 2000 | 663 | 0.030 |
Why?
|
| Blood Coagulation Disorders | 1 | 2000 | 350 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 4111 | 0.030 |
Why?
|
| Pleural Neoplasms | 1 | 2001 | 609 | 0.030 |
Why?
|
| Incidental Findings | 2 | 2013 | 697 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1996 | 131 | 0.030 |
Why?
|
| Age Distribution | 2 | 2014 | 2880 | 0.030 |
Why?
|
| Face | 2 | 2017 | 1026 | 0.030 |
Why?
|
| Mutation, Missense | 2 | 2016 | 2571 | 0.030 |
Why?
|
| Cryptogenic Organizing Pneumonia | 1 | 1996 | 28 | 0.030 |
Why?
|
| Tracheal Stenosis | 1 | 1998 | 228 | 0.030 |
Why?
|
| Estradiol | 1 | 1983 | 1937 | 0.030 |
Why?
|
| Genome, Human | 1 | 2009 | 4425 | 0.030 |
Why?
|
| PPAR delta | 1 | 2015 | 40 | 0.030 |
Why?
|
| Hepatectomy | 2 | 2010 | 557 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2017 | 255 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2005 | 2161 | 0.030 |
Why?
|
| Fingers | 1 | 1979 | 507 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2017 | 17904 | 0.030 |
Why?
|
| Adenoma, Liver Cell | 1 | 1995 | 32 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2004 | 1626 | 0.030 |
Why?
|
| Mediastinal Neoplasms | 1 | 1998 | 401 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1998 | 638 | 0.030 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2017 | 324 | 0.030 |
Why?
|
| Hepatic Veins | 1 | 1995 | 112 | 0.030 |
Why?
|
| Urethra | 1 | 1997 | 405 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2005 | 2047 | 0.030 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2005 | 1428 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2015 | 200 | 0.030 |
Why?
|
| Cholecystitis | 1 | 1996 | 180 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 2425 | 0.030 |
Why?
|
| Splenic Diseases | 1 | 1995 | 90 | 0.030 |
Why?
|
| Thoracic Diseases | 1 | 1996 | 99 | 0.030 |
Why?
|
| Vaginal Neoplasms | 2 | 2005 | 104 | 0.030 |
Why?
|
| Rabbits | 3 | 2006 | 4772 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2005 | 4003 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2024 | 2416 | 0.030 |
Why?
|
| Risk Factors | 8 | 2017 | 74206 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 1995 | 241 | 0.030 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2005 | 2020 | 0.030 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2014 | 128 | 0.030 |
Why?
|
| Root Resorption | 2 | 2011 | 44 | 0.030 |
Why?
|
| Kidney Calices | 1 | 1974 | 26 | 0.030 |
Why?
|
| Aneuploidy | 1 | 1998 | 551 | 0.030 |
Why?
|
| Diseases in Twins | 1 | 1996 | 446 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2011 | 1755 | 0.030 |
Why?
|
| Vulvar Diseases | 1 | 1994 | 64 | 0.030 |
Why?
|
| Gene Dosage | 2 | 2013 | 1217 | 0.030 |
Why?
|
| Animals | 12 | 2024 | 168459 | 0.030 |
Why?
|
| Self-Examination | 1 | 2013 | 71 | 0.030 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 2006 | 329 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2017 | 1541 | 0.030 |
Why?
|
| Osteomalacia | 1 | 2013 | 60 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2016 | 3606 | 0.030 |
Why?
|
| Eosinophils | 1 | 1998 | 950 | 0.030 |
Why?
|
| Pentetic Acid | 1 | 1993 | 209 | 0.030 |
Why?
|
| Nose Neoplasms | 1 | 2015 | 249 | 0.030 |
Why?
|
| Radionuclide Imaging | 2 | 2013 | 1972 | 0.030 |
Why?
|
| Contrast Media | 3 | 2009 | 5311 | 0.030 |
Why?
|
| Orchiectomy | 1 | 2015 | 463 | 0.030 |
Why?
|
| Mastectomy | 1 | 2021 | 1822 | 0.030 |
Why?
|
| Eczema | 1 | 1996 | 246 | 0.030 |
Why?
|
| Meglumine | 1 | 1993 | 144 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 169 | 0.030 |
Why?
|
| Kidney | 2 | 2001 | 7048 | 0.030 |
Why?
|
| Review Literature as Topic | 1 | 2015 | 348 | 0.030 |
Why?
|
| Thoracic Neoplasms | 2 | 1997 | 267 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 1995 | 652 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2015 | 598 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 1995 | 737 | 0.030 |
Why?
|
| Spleen | 2 | 1995 | 2295 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 1996 | 983 | 0.030 |
Why?
|
| Alkylating Agents | 1 | 1993 | 133 | 0.030 |
Why?
|
| Iodized Oil | 1 | 1972 | 10 | 0.030 |
Why?
|
| Postoperative Complications | 5 | 2010 | 15631 | 0.030 |
Why?
|
| Tooth Mobility | 1 | 2011 | 21 | 0.030 |
Why?
|
| Testosterone | 1 | 1983 | 2472 | 0.030 |
Why?
|
| Chordoma | 1 | 2015 | 347 | 0.030 |
Why?
|
| Trachea | 1 | 1998 | 1089 | 0.020 |
Why?
|
| Inflammation | 3 | 2010 | 10773 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 1281 | 0.020 |
Why?
|
| Arteriovenous Fistula | 1 | 1995 | 319 | 0.020 |
Why?
|
| Abscess | 1 | 1996 | 606 | 0.020 |
Why?
|
| Palatal Neoplasms | 1 | 2011 | 37 | 0.020 |
Why?
|
| Curettage | 1 | 2011 | 74 | 0.020 |
Why?
|
| Brain Stem | 1 | 2017 | 858 | 0.020 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2013 | 155 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2009 | 5368 | 0.020 |
Why?
|
| Interleukin-3 | 1 | 1993 | 425 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2001 | 2448 | 0.020 |
Why?
|
| Cytogenetics | 2 | 2006 | 198 | 0.020 |
Why?
|
| Urinary Bladder Diseases | 1 | 1992 | 167 | 0.020 |
Why?
|
| Emulsions | 1 | 1972 | 152 | 0.020 |
Why?
|
| Uterus | 2 | 2005 | 649 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2009 | 592 | 0.020 |
Why?
|
| Bronchi | 1 | 1995 | 845 | 0.020 |
Why?
|
| Tumor Virus Infections | 1 | 1994 | 438 | 0.020 |
Why?
|
| Endometrial Neoplasms | 1 | 2001 | 1366 | 0.020 |
Why?
|
| Mandibular Condyle | 1 | 2011 | 115 | 0.020 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 15266 | 0.020 |
Why?
|
| Carcinoid Tumor | 1 | 1993 | 224 | 0.020 |
Why?
|
| Lymphography | 1 | 1972 | 188 | 0.020 |
Why?
|
| Oral Ulcer | 1 | 2011 | 96 | 0.020 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 1992 | 98 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2001 | 2856 | 0.020 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2012 | 245 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1998 | 1374 | 0.020 |
Why?
|
| Mandibular Neoplasms | 1 | 2011 | 130 | 0.020 |
Why?
|
| Middle Aged | 11 | 2017 | 220895 | 0.020 |
Why?
|
| Factor VIII | 2 | 1991 | 348 | 0.020 |
Why?
|
| Hodgkin Disease | 1 | 1998 | 1378 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 1991 | 127 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2015 | 3639 | 0.020 |
Why?
|
| Endothelium, Vascular | 3 | 2010 | 4431 | 0.020 |
Why?
|
| Trisomy | 2 | 2008 | 260 | 0.020 |
Why?
|
| Mediastinum | 1 | 1972 | 267 | 0.020 |
Why?
|
| Catalysis | 1 | 2012 | 774 | 0.020 |
Why?
|
| Thyroiditis | 1 | 2010 | 86 | 0.020 |
Why?
|
| Inclusion Bodies | 2 | 2004 | 281 | 0.020 |
Why?
|
| Cough | 1 | 2014 | 594 | 0.020 |
Why?
|
| Adipocytes | 1 | 2017 | 1194 | 0.020 |
Why?
|
| Mice | 5 | 2024 | 81525 | 0.020 |
Why?
|
| Pleura | 1 | 1972 | 245 | 0.020 |
Why?
|
| Cell Death | 1 | 2015 | 1678 | 0.020 |
Why?
|
| Leukocytes | 1 | 1998 | 2026 | 0.020 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1991 | 167 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2004 | 755 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2011 | 6814 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12059 | 0.020 |
Why?
|
| Basement Membrane | 2 | 1997 | 349 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 1991 | 313 | 0.020 |
Why?
|
| Myocardium | 2 | 2009 | 4726 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 1993 | 647 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 2013 | 4615 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2013 | 815 | 0.020 |
Why?
|
| Cystadenoma, Mucinous | 1 | 2009 | 62 | 0.020 |
Why?
|
| Pulmonary Veins | 1 | 1995 | 743 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1993 | 891 | 0.020 |
Why?
|
| Reoperation | 1 | 2020 | 4303 | 0.020 |
Why?
|
| Carotid Artery, External | 1 | 2009 | 37 | 0.020 |
Why?
|
| Arthralgia | 1 | 2013 | 461 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2015 | 1893 | 0.020 |
Why?
|
| Parovarian Cyst | 1 | 1988 | 1 | 0.020 |
Why?
|
| Mesna | 1 | 2008 | 62 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2015 | 1271 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2011 | 441 | 0.020 |
Why?
|
| Vincristine | 2 | 2008 | 1036 | 0.020 |
Why?
|
| Papio | 1 | 2010 | 669 | 0.020 |
Why?
|
| Asthma | 3 | 1998 | 6234 | 0.020 |
Why?
|
| Streptococcus pneumoniae | 1 | 2014 | 730 | 0.020 |
Why?
|
| Mosaicism | 1 | 2012 | 475 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 662 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2013 | 2180 | 0.020 |
Why?
|
| Hyperoxia | 1 | 2010 | 258 | 0.020 |
Why?
|
| Megakaryocytes | 1 | 1993 | 566 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2013 | 1186 | 0.020 |
Why?
|
| Disease Progression | 4 | 2008 | 13506 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2014 | 622 | 0.020 |
Why?
|
| Radiography, Thoracic | 3 | 2006 | 1302 | 0.020 |
Why?
|
| Ifosfamide | 1 | 2008 | 232 | 0.020 |
Why?
|
| Sarcoma, Synovial | 1 | 2009 | 153 | 0.020 |
Why?
|
| Status Asthmaticus | 1 | 1988 | 22 | 0.020 |
Why?
|
| Peritoneal Diseases | 1 | 1988 | 75 | 0.020 |
Why?
|
| Genes, myc | 3 | 1996 | 390 | 0.020 |
Why?
|
| Demography | 1 | 2013 | 1648 | 0.020 |
Why?
|
| Stomach | 1 | 1992 | 696 | 0.020 |
Why?
|
| Aorta | 1 | 2015 | 2042 | 0.020 |
Why?
|
| Mesoderm | 2 | 2001 | 674 | 0.020 |
Why?
|
| Chylothorax | 1 | 2008 | 83 | 0.020 |
Why?
|
| Image Enhancement | 3 | 2011 | 2885 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 1779 | 0.020 |
Why?
|
| Bacteriological Techniques | 1 | 1989 | 275 | 0.020 |
Why?
|
| Physical Examination | 1 | 2013 | 1255 | 0.020 |
Why?
|
| Injections | 2 | 2006 | 830 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 1992 | 709 | 0.020 |
Why?
|
| Esophagitis | 1 | 1988 | 164 | 0.020 |
Why?
|
| Tissue Adhesions | 1 | 1988 | 218 | 0.020 |
Why?
|
| Etoposide | 1 | 2008 | 634 | 0.020 |
Why?
|
| Metaphase | 2 | 2001 | 145 | 0.020 |
Why?
|
| Melphalan | 1 | 2008 | 420 | 0.020 |
Why?
|
| Epiphyses | 1 | 1988 | 190 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 4243 | 0.020 |
Why?
|
| Granuloma, Giant Cell | 1 | 1986 | 32 | 0.020 |
Why?
|
| Fever | 1 | 2014 | 1618 | 0.020 |
Why?
|
| Genotype | 2 | 2017 | 12990 | 0.020 |
Why?
|
| Mitosis | 1 | 2011 | 1187 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 1996 | 2651 | 0.020 |
Why?
|
| Gene Amplification | 3 | 2000 | 1089 | 0.020 |
Why?
|
| Echocardiography | 2 | 2012 | 4989 | 0.020 |
Why?
|
| Glottis | 1 | 2008 | 214 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1995 | 1298 | 0.020 |
Why?
|
| Giant Cell Tumors | 1 | 1986 | 89 | 0.020 |
Why?
|
| Osteotomy | 1 | 2011 | 837 | 0.020 |
Why?
|
| Stents | 1 | 1998 | 3179 | 0.020 |
Why?
|
| Referral and Consultation | 2 | 2012 | 3600 | 0.020 |
Why?
|
| Incidence | 2 | 2015 | 21353 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2013 | 1742 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 1860 | 0.020 |
Why?
|
| Jaw Diseases | 1 | 1986 | 92 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2008 | 629 | 0.020 |
Why?
|
| Remission Induction | 1 | 2011 | 2396 | 0.020 |
Why?
|
| Mucus | 1 | 1988 | 341 | 0.020 |
Why?
|
| Endothelium | 1 | 2008 | 765 | 0.020 |
Why?
|
| Emphysema | 1 | 2008 | 238 | 0.020 |
Why?
|
| Calcinosis | 3 | 2000 | 1469 | 0.020 |
Why?
|
| Esophageal Atresia | 1 | 1988 | 225 | 0.020 |
Why?
|
| Cell Survival | 1 | 2015 | 5791 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2011 | 2341 | 0.020 |
Why?
|
| Carboplatin | 1 | 2008 | 794 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 2010 | 785 | 0.020 |
Why?
|
| Fetal Development | 1 | 2011 | 769 | 0.020 |
Why?
|
| Pulse | 1 | 2005 | 217 | 0.020 |
Why?
|
| Exons | 1 | 2011 | 2391 | 0.020 |
Why?
|
| Urachal Cyst | 1 | 2004 | 7 | 0.020 |
Why?
|
| Ameloblastoma | 1 | 1985 | 42 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2007 | 473 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2010 | 1008 | 0.010 |
Why?
|
| Knee Joint | 1 | 2013 | 1676 | 0.010 |
Why?
|
| Morbidity | 1 | 2010 | 1750 | 0.010 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2008 | 549 | 0.010 |
Why?
|
| Barrett Esophagus | 1 | 1988 | 492 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2011 | 2358 | 0.010 |
Why?
|
| Metapneumovirus | 1 | 2004 | 28 | 0.010 |
Why?
|
| Temporal Bone | 1 | 2009 | 683 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2017 | 3537 | 0.010 |
Why?
|
| Prevalence | 2 | 2013 | 15732 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 22169 | 0.010 |
Why?
|
| Airway Obstruction | 2 | 2006 | 661 | 0.010 |
Why?
|
| Macrostomia | 1 | 2003 | 6 | 0.010 |
Why?
|
| Circumcision, Male | 1 | 2005 | 148 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 1995 | 283 | 0.010 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2005 | 143 | 0.010 |
Why?
|
| Osteoclasts | 1 | 2008 | 711 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1999 | 3164 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2005 | 375 | 0.010 |
Why?
|
| Facial Neoplasms | 1 | 2005 | 125 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3416 | 0.010 |
Why?
|
| Alleles | 1 | 2015 | 6863 | 0.010 |
Why?
|
| Fluorouracil | 1 | 2008 | 1641 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 1993 | 2049 | 0.010 |
Why?
|
| Sertoli Cells | 1 | 1983 | 50 | 0.010 |
Why?
|
| Desmosomes | 1 | 1983 | 72 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2645 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2011 | 2665 | 0.010 |
Why?
|
| Oligospermia | 1 | 1983 | 59 | 0.010 |
Why?
|
| Neuroendocrine Tumors | 1 | 2009 | 641 | 0.010 |
Why?
|
| Receptors, Peptide | 1 | 2005 | 279 | 0.010 |
Why?
|
| Intestines | 1 | 1992 | 1909 | 0.010 |
Why?
|
| Algorithms | 2 | 2007 | 14031 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 4915 | 0.010 |
Why?
|
| Intermittent Claudication | 1 | 2005 | 304 | 0.010 |
Why?
|
| Propylthiouracil | 1 | 2002 | 68 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 1379 | 0.010 |
Why?
|
| Sports | 1 | 2009 | 705 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2008 | 2218 | 0.010 |
Why?
|
| Calcitonin | 1 | 2004 | 329 | 0.010 |
Why?
|
| Cisplatin | 1 | 2008 | 1651 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2008 | 1143 | 0.010 |
Why?
|
| Femur | 1 | 1989 | 1307 | 0.010 |
Why?
|
| Contracture | 1 | 2005 | 235 | 0.010 |
Why?
|
| Papillomavirus Infections | 1 | 1994 | 1613 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 2020 | 0.010 |
Why?
|
| Methods | 2 | 1995 | 1067 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2012 | 3442 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2011 | 10090 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2004 | 412 | 0.010 |
Why?
|
| Spine | 1 | 1989 | 1118 | 0.010 |
Why?
|
| Massachusetts | 1 | 2014 | 8830 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 2005 | 1096 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1987 | 1515 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2007 | 3597 | 0.010 |
Why?
|
| Glycogen Storage Disease Type I | 2 | 1995 | 53 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 13446 | 0.010 |
Why?
|
| Keratin-14 | 1 | 2001 | 56 | 0.010 |
Why?
|
| Urogenital System | 1 | 2001 | 88 | 0.010 |
Why?
|
| Tongue Neoplasms | 1 | 2002 | 183 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 2693 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2006 | 1745 | 0.010 |
Why?
|
| Comorbidity | 1 | 2015 | 10508 | 0.010 |
Why?
|
| Colon | 1 | 1988 | 1792 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2005 | 1129 | 0.010 |
Why?
|
| Sclerosis | 1 | 2001 | 210 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 17635 | 0.010 |
Why?
|
| Cardiomyopathies | 2 | 1995 | 1964 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2015 | 14414 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2005 | 2115 | 0.010 |
Why?
|
| Chromosome Breakage | 1 | 2000 | 159 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2011 | 2072 | 0.010 |
Why?
|
| Glucuronosyltransferase | 1 | 2000 | 132 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 4740 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2011 | 15936 | 0.010 |
Why?
|
| United States | 3 | 2013 | 72334 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1987 | 1336 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 22176 | 0.010 |
Why?
|
| DNA, Viral | 2 | 1997 | 2202 | 0.010 |
Why?
|
| Clone Cells | 2 | 1994 | 1659 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 2000 | 441 | 0.010 |
Why?
|
| Ethanol | 1 | 2005 | 1324 | 0.010 |
Why?
|
| Receptor, trkC | 1 | 1998 | 63 | 0.010 |
Why?
|
| Cicatrix | 1 | 2005 | 798 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2010 | 2827 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1995 | 4671 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 2001 | 497 | 0.010 |
Why?
|
| Aged | 4 | 2017 | 169289 | 0.010 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2009 | 1727 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1991 | 2298 | 0.010 |
Why?
|
| Teratoma | 1 | 1981 | 404 | 0.010 |
Why?
|
| Hemosiderin | 1 | 1997 | 41 | 0.010 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 1997 | 41 | 0.010 |
Why?
|
| Age Factors | 2 | 2009 | 18395 | 0.010 |
Why?
|
| Urogenital Abnormalities | 1 | 2001 | 261 | 0.010 |
Why?
|
| Ecchymosis | 1 | 1997 | 32 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2001 | 1900 | 0.010 |
Why?
|
| Acute Disease | 2 | 2000 | 7237 | 0.010 |
Why?
|
| Menstrual Cycle | 1 | 2001 | 539 | 0.010 |
Why?
|
| Prospective Studies | 5 | 2006 | 54425 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2005 | 2208 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2004 | 1265 | 0.010 |
Why?
|
| Lymphoma | 1 | 1986 | 1901 | 0.010 |
Why?
|
| Thyrotropin | 1 | 2000 | 834 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 4544 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 12463 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 1062 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2000 | 1371 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1997 | 445 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 1624 | 0.010 |
Why?
|
| Ploidies | 1 | 1996 | 285 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2001 | 1870 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 1993 | 4876 | 0.010 |
Why?
|
| Angiography | 1 | 2001 | 1595 | 0.010 |
Why?
|
| Macrophages | 1 | 2010 | 5769 | 0.010 |
Why?
|
| Sheep | 1 | 1998 | 1440 | 0.010 |
Why?
|
| Mucopolysaccharidosis I | 1 | 1995 | 52 | 0.010 |
Why?
|
| Tuberous Sclerosis | 1 | 1983 | 1030 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 13255 | 0.010 |
Why?
|
| Thoracoscopy | 1 | 1996 | 181 | 0.010 |
Why?
|
| Atrophy | 1 | 2000 | 1633 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 4174 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 6374 | 0.010 |
Why?
|
| Oncogenes | 1 | 2000 | 1222 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 58976 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 1995 | 321 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 1994 | 97 | 0.010 |
Why?
|
| Cell Count | 1 | 1998 | 1835 | 0.010 |
Why?
|
| Tracheostomy | 1 | 1998 | 426 | 0.010 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1997 | 333 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 1997 | 659 | 0.010 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 1997 | 384 | 0.010 |
Why?
|
| Collagenases | 1 | 1994 | 222 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2000 | 1502 | 0.010 |
Why?
|
| Heart | 1 | 1987 | 4404 | 0.010 |
Why?
|
| Glycoproteins | 2 | 1994 | 2203 | 0.010 |
Why?
|
| Cholecystectomy | 1 | 1996 | 406 | 0.010 |
Why?
|
| Kidney Medulla | 1 | 1974 | 169 | 0.010 |
Why?
|
| Edema | 1 | 1997 | 766 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 1997 | 921 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 14605 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1994 | 767 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14666 | 0.010 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 1995 | 227 | 0.010 |
Why?
|
| Age of Onset | 1 | 2000 | 3305 | 0.010 |
Why?
|
| Fanconi Anemia | 1 | 1995 | 324 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 1993 | 352 | 0.010 |
Why?
|
| Catheterization | 1 | 1998 | 1428 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2005 | 18252 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1998 | 2678 | 0.010 |
Why?
|
| Cell Division | 2 | 1995 | 4465 | 0.010 |
Why?
|
| Ethiodized Oil | 1 | 1972 | 26 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2010 | 12953 | 0.010 |
Why?
|
| Vena Cava, Inferior | 1 | 1995 | 458 | 0.010 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 1995 | 292 | 0.010 |
Why?
|
| Carcinoma in Situ | 1 | 1997 | 791 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 1994 | 673 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 1992 | 362 | 0.010 |
Why?
|
| Gadolinium | 1 | 1996 | 960 | 0.010 |
Why?
|
| Lymphokines | 1 | 1994 | 927 | 0.010 |
Why?
|
| Granulocytes | 1 | 1993 | 551 | 0.010 |
Why?
|
| Surgical Wound Dehiscence | 1 | 1992 | 213 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 1994 | 632 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1982 | 3096 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1982 | 3424 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 3627 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1991 | 410 | 0.010 |
Why?
|
| Apoptosis | 1 | 2005 | 9486 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1998 | 1551 | 0.010 |
Why?
|
| Fatty Liver | 1 | 1995 | 790 | 0.010 |
Why?
|
| Cytological Techniques | 1 | 1991 | 218 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2000 | 5789 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 1998 | 1285 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1982 | 6377 | 0.000 |
Why?
|
| Epithelial Cells | 1 | 2001 | 3673 | 0.000 |
Why?
|
| Body Temperature | 1 | 1972 | 781 | 0.000 |
Why?
|
| Ascitic Fluid | 1 | 1988 | 189 | 0.000 |
Why?
|
| Exudates and Transudates | 1 | 1988 | 174 | 0.000 |
Why?
|
| Chromatography, Thin Layer | 1 | 1988 | 213 | 0.000 |
Why?
|
| Observer Variation | 1 | 1994 | 2606 | 0.000 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1988 | 299 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1998 | 5869 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 6534 | 0.000 |
Why?
|
| Leukocyte Count | 1 | 1972 | 1596 | 0.000 |
Why?
|
| Obesity | 1 | 2010 | 12947 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1993 | 2048 | 0.000 |
Why?
|
| Mast Cells | 1 | 1994 | 1392 | 0.000 |
Why?
|
| Dogs | 1 | 1972 | 3839 | 0.000 |
Why?
|
| Cell Differentiation | 2 | 2001 | 11528 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 6132 | 0.000 |
Why?
|
| Liver Glycogen | 1 | 1986 | 35 | 0.000 |
Why?
|
| Muscles | 1 | 1991 | 1576 | 0.000 |
Why?
|
| Carnitine | 1 | 1986 | 252 | 0.000 |
Why?
|
| Respiratory System | 1 | 1988 | 563 | 0.000 |
Why?
|
| Ovary | 1 | 1988 | 959 | 0.000 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1986 | 284 | 0.000 |
Why?
|
| Urea | 1 | 1986 | 443 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1988 | 1085 | 0.000 |
Why?
|
| Head and Neck Neoplasms | 1 | 1997 | 2895 | 0.000 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 1994 | 3492 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1986 | 1510 | 0.000 |
Why?
|
| Sacrococcygeal Region | 1 | 1981 | 53 | 0.000 |
Why?
|
| Prednisone | 1 | 1986 | 1563 | 0.000 |
Why?
|
| von Willebrand Factor | 1 | 1985 | 673 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1996 | 9318 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1993 | 3396 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1997 | 6346 | 0.000 |
Why?
|
| Antigens | 1 | 1985 | 1443 | 0.000 |
Why?
|
| Doxorubicin | 1 | 1986 | 2224 | 0.000 |
Why?
|
| Neoplasm Transplantation | 1 | 1981 | 2016 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1997 | 13639 | 0.000 |
Why?
|
| Mice, Nude | 1 | 1981 | 3615 | 0.000 |
Why?
|
| Transplantation, Heterologous | 1 | 1981 | 2385 | 0.000 |
Why?
|